TT

Tenvie Therapeutics at SfN 2026

Nov 14–18, 2026 Washington, DC ~21k attendees Website

Tenvie Therapeutics brings 3 presentations to SfN 2026 in Washington. Its SfN 2026 presentations centre on protecting nerve fibres from degeneration and targeting brain inflammation linked to obesity. One thread explores how blocking SARM1 may protect nerve fibres and support clinical evaluation.

OrganizationSfN 2026 Attendance
TT
Tenvie Therapeutics
Brisbane, CA
Drug developers
Biotechnology company developing medicines for neurological and psychiatric disorders.
Poster
Mon Nov 16
1–5pm
Poster
Mon Nov 16
1–5pm
Poster
Wed Nov 18
1–5pm

Explore the full SfN 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full SfN 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Tenvie Therapeutics

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Society for Neuroscience. Organization details are derived from SfN’s published exhibitor list, its Neuroscience Meeting Planner and each organization’s own website. Submit a correction